期刊文献+

鹿红颗粒干预心肌梗死后心功能不全的临床研究 被引量:4

Clinical Observation on Luhong Granules in Intervening Heart Dysfunction after Myocardial Infarction
下载PDF
导出
摘要 目的观察鹿红颗粒对心肌梗死(MI)后阳虚血瘀证心功能不全患者的心功能及心室重构的影响。方法 60例确诊为MI后心功能不全且中医辨证为阳虚血瘀证的患者随机分为对照组与干预组,各30例。对照组给予标准西药治疗,干预组在对照组治疗基础上加用鹿红颗粒,观察周期3个月。观察用药前后两组患者的中医临床症状,检测指标:血浆B型脑钠肽(BNP)、血浆血管紧张素Ⅱ(AngⅡ)、血浆去甲肾上腺素(NE)、左室舒张末内径(LVEDD)、左室收缩末内径(LVESD)、左室射血分数(LVEF)、室间隔厚度(IVST)、左室后壁厚度(LVPWT)。结果两组用药前后NE和BNP有统计学意义(P<0.01);两组用药前后BNP差值比较有统计学意义(P<0.01),两组治疗前后AngⅡ无统计学意义(P>0.05)。干预组治疗前后LVESD有统计学意义(P<0.05);两组用药前后LVESD差值比较有统计学意义(P<0.05),其他指标均无统计学意义(P>0.05)。干预组用药后中医临床症状有效率优于对照组(P<0.01)。结论在标准西药治疗基础上加载鹿红颗粒治疗能够改善MI后心功能不全患者BNP、LVEF、LVESD及中医临床症状,疗效优于单纯标准西药治疗。 Objective To investigate the effects of Luhong granules(LHG) on heart function and ventricular remodeling in patients with heart dysfunction after myocardial infarction and yang deficiency and blood stasis syndrome. Methods Sixty patients with heart dys- function after myocardial infarction and yang deficiency and blood stasis syndrome were randomly divided into two groups,The con- trol group( n = 30) treated with routine treatment and the treatment group( n = 30)treated with LHG on the basis of routine treatment for 3 months. Before and after treatment,the symptoms of traditional Chinese medicine, B- type natriuretic peptide(BNP), angioten- sin H (Ang Ⅱ ), norepinephrine(NE), left ventricular(LV)end diastolic dimension (LVEDD), LV end -systolic dimension(LVESD), LV ejection fraction (LVEF), inter- ventricular septal thickness (IVST), LV posterior wall thickness (LVPWT) were observed. Results After treatment, NE and BNP levels in two groups had very more significant improvement( P ~0. 01). BNP level in treatment group was higher than that in the control group ( P 〈0. 01). There were no difference in AngH between two groups before and after treat- ment( P 〉0. 05). LVESD had significant improvement in the treatment group after treatment ( P 〈0. 05) ; Difference value of LVESD in treatment group was more improved than in the control group ( P 〈0. 05). The effective rate of the symptoms of traditional Chi- nese medicine were 93. 4% in treatment group, 13. 3% in control group ( P 〈0. 05). Conclusion LHG plus routine treatment can improve the BNP,LVEF,LVESD and clinical symptoms in patients with heart dysfunction after myocardial infarction and yang defi- ciency and blood stasis syndrome.
出处 《中西医结合心脑血管病杂志》 2015年第9期1063-1066,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 国家"863"项目"综合性中医院信息系统研发与示范"(2012AA02A610) 吴阶平基金会临床科研专项资助基金(No.320.6750.12183) 上海市科委科技支撑项目(No.12401903400) 上海市卫生局科研项目(No.20124069)
关键词 心肌梗死 心室重构 心功能不全 鹿红颗粒 myocardial infarction ventricular remodeling heart failure Luhong granules
  • 相关文献

参考文献8

  • 1郁秀娟,丁晓梅.心肌梗死后心室重构研究进展[J].中华临床医师杂志(电子版),2013,7(2):144-146. 被引量:12
  • 2John JV, McMurray SA,Stefan DA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 [J]. Eur Heart ,2012,33(13) : 1635 - 1701.
  • 3中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量:4665
  • 4中华医学会心血管病分会,中华心血管病杂志编辑委员会.急性ST段抬高心肌梗死的诊断和治疗指南[J].中华心血管病杂志,2010,8(38):675-680.
  • 5中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128.
  • 6中国中西医结合学会活血化瘀专业委员会.血瘀证诊断标准[J].中国中西医结合杂志,1987,7(3):129-131.
  • 7刘焱,余振亚,刘坤申.基质金属蛋白酶及其抑制剂与心脏重构[J].心血管病学进展,2004,25(B12):99-101. 被引量:2
  • 8Hunt SA,Abraham WT, Chin MH, et al. ACC/AHA2005 Guide line Update for the Diagnosis and Management of Chronic Heart Failure in the Adult[J]. Circulation, 2005,112(12) : 154 - 235.

二级参考文献54

  • 1Peterson JT,Li H,Dillonl.Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infarcted rat[J].Cardiovasc Res,2000,46(2):307-315.
  • 2Zhang Dl,Menashe BE,Meloche S,et al.Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor[J].J Biol Chem,2004,279,19683-19690.
  • 3Rozanov DV,Deryugina EI,Ratnikov BI,et al.Mutation analysis of membranetype-1 matrix metalloproteinase (MT1-MMP) [J].Biol Chem,2001,276.
  • 4Reunanen N,Li SP,Ahonen M,et al.Activation of p38 MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization[J].J Biol Chem,2002,277(35):32360-32368.
  • 5Sakata Y,Yamamoto Y,Mano T,et al.Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of angiotensin-converting enzyme inhibitor[J].Circulation,2004,109(17): 21
  • 6Spinale FG,Coker ML,Thomas CV,et al.Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function[J].Circ Res,1998,82:482-495.
  • 7Ravanti L,Heino J,López-Otín C,et al.Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase[J].J Biol Chem,1999,274:2446-2455.
  • 8Mukherjee R,Parkherjee AM,Mingoia JT,et al.Myocardial remodeling after discrete radiofrequency injury:effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion[J].Am J Physiol Heart Circ Physiol,2004,286:H1242-H1247.
  • 9Roten L,Nemoto S,Simsic J,et al.Effect of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type1(TIMP-1) on left ventricular geometry and function in mice[J].J Mol Cell Cardiol,2000,32:109-120.
  • 10Hayashidani S,Tsutsui H,Ikeuchi M,et al.Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction[J].Am J Physiol Heart Circ Physiol,2003, 285(3): H1229-H1235

共引文献5140

同被引文献26

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部